Free Trial

Synopsys, Inc. (NASDAQ:SNPS) Stake Lessened by Centiva Capital LP

Synopsys logo with Computer and Technology background

Centiva Capital LP cut its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 54.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,494 shares of the semiconductor company's stock after selling 1,764 shares during the period. Centiva Capital LP's holdings in Synopsys were worth $725,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Kieckhefer Group LLC purchased a new position in Synopsys in the fourth quarter valued at approximately $27,000. Whipplewood Advisors LLC purchased a new stake in Synopsys during the 4th quarter worth $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Synopsys in the 4th quarter valued at $34,000. Sierra Ocean LLC purchased a new position in Synopsys in the fourth quarter valued at about $39,000. Finally, Hazlett Burt & Watson Inc. lifted its stake in shares of Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on SNPS. Redburn Atlantic started coverage on Synopsys in a research report on Monday, January 13th. They set a "buy" rating and a $600.00 price target on the stock. Stifel Nicolaus set a $550.00 price target on shares of Synopsys in a report on Monday, April 28th. Piper Sandler cut their price objective on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Morgan Stanley lowered their target price on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research note on Monday, February 24th. Finally, Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 price target on shares of Synopsys in a research note on Tuesday, February 25th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $613.43.

View Our Latest Stock Report on SNPS

Synopsys Price Performance

Shares of NASDAQ:SNPS traded up $10.12 during trading on Tuesday, reaching $515.71. 821,323 shares of the company's stock traded hands, compared to its average volume of 1,101,422. The company has a 50 day moving average of $438.34 and a 200-day moving average of $489.05. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The stock has a market capitalization of $79.74 billion, a P/E ratio of 35.52, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.

Insider Activity

In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the sale, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares in the company, valued at approximately $51,850,925.82. This trade represents a 11.86% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company's stock.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines